コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ng that this effect is specific to the human IL-15 receptor.
2 ated upregulation of interleukin (IL)-15 and IL-15 receptor.
3 122, the beta-subunit shared by the IL-2 and IL-15 receptors.
4 on of IL-12, IL-15, and IL-18 or the IL-2 or IL-15 receptors.
5 is shared by the IL-2, IL-4, IL-7, IL-9 and IL-15 receptors.
6 mma chain of the IL-2, IL-4, IL-7, IL-9, and IL-15 receptors.
7 is distinct from known components of T-cell IL-15 receptors.
10 ht NK cells from MM patients primed with the IL-15 receptor agonist ALT-803 in vivo displayed enhance
14 expression of the single-chain IL-15 and the IL-15 receptor alpha (IL-15Ralpha) in the same cell allo
15 co-expression of interleukin 15 (IL-15) and IL-15 receptor alpha (IL-15Ralpha) in the same cell allo
17 ion proteins have been engineered to provide IL-15 receptor alpha (IL-15Ralpha) mediated trans-presen
18 n 3 (MCP-3), IL-2 receptor beta (IL-2Rbeta), IL-15 receptor alpha (IL-15Ralpha), interferon receptor
20 e treated T. gondii immune mice with soluble IL-15 receptor alpha (sIL-15Ralpha) to block the host en
24 ing molecule (Bim), interleukin (IL)-15, and IL-15 receptor alpha chain (IL-15R alpha ) were associat
26 ed that these tolerant T cells expressed the IL-15 receptor alpha chain, and could be induced to prol
28 GF-beta) receptor II and interleukin (IL)-15/IL-15 receptor alpha domains, enhances metabolic and cyt
32 timulatory cytokine trans-presented with the IL-15 receptor alpha-chain to the shared IL-2/IL-15Rbeta
35 ation of CD40 led to increased expression of IL-15 receptor-alpha by dendritic cells, an action that
37 anscription factors for development, but not IL-15 receptor-alpha, indicating that intraepithelial IL
38 by treating mice with IL-15 precomplexed to IL-15 receptor-alpha, which induced the development of e
39 in (IL)-15 superagonist mutant and a dimeric IL-15 receptor alphaSu/Fc fusion protein, was found to e
40 unts of the antiapoptotic protein Bcl-2, the IL-15 receptor and the receptor CD27, and little homeost
42 noclonal antibodies targeting either IL-2 or IL-15 receptors and safer than inhibitors of downstream
43 increase in CD4(+) T cells was recorded with IL-15 receptors, APOBEC3G and CC chemokines, the latter
44 flt3/flk2, CXCR4, the IL-7 receptor and the IL-15 receptor - are known to promote the expansion and
48 of the transcription factors T-bet, the IL-2/IL-15 receptor beta chain CD122, and suppression of eome
50 etal thymus were activated and expressed the IL-15 receptor beta chain, skin-homing receptors, and th
51 to the relatively high expression levels of IL-15 receptor beta, IL-7 receptor, IL-18 receptor, and
52 er signaling via CD122 (interleukin-2 [IL-2]/IL-15 receptor beta-chain) plays a role in regulating th
53 alpha production by IL-15 required the (IL-2/IL-15) receptor beta chain, as demonstrated by receptor
58 KG2A(+)KLRG1(+) CD8 T cells express IL-7 and IL-15 receptors, can survive long-term without cognate A
60 ation and molecular association of IL-2 (and IL-15) receptor chains in the ER/Golgi, which became mor
61 ntified a gene-gene interaction between IL-2/IL-15 receptor common beta chain and IL-2/IL-7/IL-15 rec
63 estigated for defects in the interleukin-15 (IL-15) receptor complex because functional IL-15 signali
64 CH1 and RBPJ, as well as the interleukin-15 (IL-15) receptor complex, the latter enhancing IL-15 auto
67 he interleukin (IL)-2, IL-4, IL-7, IL-9, and IL-15 receptors, contributes to both cytokine binding an
68 igh affinity alpha-chain of the interleukin (IL)-15 receptor exists not only in membrane-anchored but
69 -cell survival but rather repressed IL-7 and IL-15 receptor expression, STAT5 phosphorylation, and BC
72 ion are regulated by IL-15, the influence of IL-15 receptor (IL-15R)-mediated signaling at the cellul
77 mice lacking the high affinity interleukin (IL)-15 receptor, IL-15Ralpha, surprisingly results in th
78 Interleukin (IL)-15 and its high affinity IL-15 receptor, IL-15Ralpha, support NK cell homeostasis
79 ibody recognizing a signaling subunit of the IL-15 receptor, IL-2/15Rbeta, had a significant ( approx
81 counter in vivo and engagement of the TCR or IL-15 receptor in vitro leads to the down-regulation of
82 interfering with the signal of the IL-2 and IL-15 receptors in a primate model of experimental autoi
84 homeostatic pathway defined by IL-15/IL-15R (IL-15 receptor) interaction and the inflammasome pathway
85 alpha was not co-precipitated from the [125I]IL-15 receptor-ligand complex, demonstrating that IL-15
86 New forms of therapy directed at IL-2 and IL-15 receptors may be effective against certain neoplas
88 ility of exploiting reagents that impact the IL-15 receptor pathway to facilitate construction of hum
92 Death of NK cells resulted from diminished IL-15 receptor signaling within miR-142-deficient mice,
94 zed that differential expression of IL-2 and IL-15 receptor subunits on cycling T cells in vivo may d
95 T-cell divisions and expression of IL-2 and IL-15 receptor subunits, we demonstrate that IL-15 is a
96 on with anti-PD1 antibody (alphaPD1) and the IL-15 receptor superagonist N-803 to increase cytolytic
97 lated cytokine receptors, including IL-7 and IL-15 receptors, that mediate nonredundant or critical s
98 vascular endothelial cells (VECs) expressed IL-15 receptors, the present study was undertaken to inv
99 modulate expression of the beta-chain of the IL-15 receptor, thus establishing a central axis between
100 and expressed reduced levels of the IL-7 and IL-15 receptors, thus providing a possible mechanism for